相关实验视频
Updated: May 8, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
147
为什么我们仍然需要新型抗肥胖药物?
Aaron Novikoff1,2, Gerald Grandl1,2, Xue Liu1,2
1Institute for Diabetes and Obesity, Helmholtz Munich, Neuherberg, Germany.
The Lancet regional health. Europe
|December 27, 2024
概括
基于葡萄糖类1 (GLP-1) 的药物正在彻底改变肥胖治疗. 先进的双重和三重受体激动剂显示显著的体重减轻,引发了关于未来抗肥胖药物开发的问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 1987年发现葡萄糖类1 (GLP-1) 的胰岛素otropic作用,标志着一个转折点.
- GLP-1受体 (GLP-1R) 激动剂已经从单激动剂演变为双 (GLP-1R/GIPR) 和三 (GLP-1R/GIPR/GcgR) 激动剂.
- 这些进展针对肥胖和相关疾病,推动制药创新.
研究的目的:
- 审查基于GLP-1的肥胖治疗方法的演变.
- 突出新型双重和三重受体激动剂的疗效.
- 讨论对未来抗肥胖药物开发的影响.
主要方法:
- 关于GLP-1受体药理学的科学文献的综述.
- 对GLP-1R,GLP-1R/GIPR和GLP-1R/GIPR/GcgR激动剂的临床试验数据的分析.
- 体重减轻结果与现有减肥手术程序的比较.
主要成果:
- 蒂尔泽帕提德 (GLP-1R/GIPR双抗体) 在72周内实现了23%的体重减轻.
- 雷塔鲁提德 (GLP-1R/GIPR/GcgR三重激动剂) 在较短的时间内实现了~25%的体重减轻.
- 这些结果超过了一些减肥手术的疗效.
结论:
- 基于GLP-1的疗法,特别是多抗原剂,表现出前所未有的减肥能力.
- 显著的疗效提出了关于新型抗肥胖药物的必要性的问题.
- 需要进一步的研究来了解这些先进疗法的长期影响和潜力.
更多相关视频
相关概念视频
Glucagon-like Receptor Agonists
250
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
250
Antidepressant Drugs: MAOIs and Other Agents
159
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
159
Oral Hypoglycemic Agents: Biguanides and Glitazones
132
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
132
Prescription, Nonprescription and Orphan Drugs
651
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
651
Regulation of Food Intake
139
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
139
Obesity
296
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
296

